02 May 2003 : Case report
PARP-1 protects the genome and suppresses tumor development: lessons from gene knock-out models
Z. WangMed Sci Monit 2003; 9(1): 76- :: ID: 15219
Abstract
Poly(ADP-ribose) polymerase (PARP-1), which catalyzes poly-ADP-ribosylation of nuclear proteins upon DNA damage, is a multifunctional molecule operative in a range of cellular processes including cell death, DNA repair and recombination, as well as in the maintenance of chromosome stability. Mice lacking PARP-1 are hypersensitive to g-radiation and exhibit telomere shortening, increased sister chromatid exchange and chromosomal aberrations, as well as chromosome gains and losses. Although low tumor incidence was observed in young animals, after multiple generations in a PARP-1 null background, mice were susceptible to malignancy. In addition, PARP-1 deficiency provoked epithelial tumor formation in mice heterozygous for p53 mutation. These tumors associated with dysfunctional telomeres and increased genomic instability, causing an LOH of p53. Interestingly, more than 45% of PARP-1–/– p53–/– mice developed brain tumors at a young age and the characteristics of these tumors are reminiscent of human medulloblastomas. We have also found that haploinsufficiency of Ku80, the DNA binding subunit of DNA-dependent protein kinase (DNA-PK), promotes HCC development in PARP-1 null mice. Molecular and cytogenetic analyses of these tumors will be discussed. Taken together, these data indicate that PARP-1 plays an important role in suppressing chromosome aberrations and tumorigenesis.
Keywords: PARP-1, p53, Ku80, genomic instability, medulloblastomas, hepatocellular carcinoma
Editorial
01 March 2023 : Editorial
Editorial: Global Surveillance of Highly Pathogenic Avian Influenza Viruses in Poultry, Wild Birds, and Mammals to Prevent a Human Influenza PandemicDOI: 10.12659/MSM.939968
Med Sci Monit 2023; 29:e939968
SARS-CoV-2/COVID-19
29 March 2023 : Editorial
Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate H...Med Sci Monit In Press; DOI: 10.12659/MSM.940519
30 March 2023 : Clinical Research
An Online Survey on the Relationship Between Positive Coping and Post-Traumatic Stress Symptoms (PTSS) of M...Med Sci Monit In Press; DOI: 10.12659/MSM.939485
09 February 2023 : Clinical Research
Evaluation of Health-Related Quality of Life and Mental Health in 729 Medical Students in Indonesia During ...Med Sci Monit 2023; 29:e938892
19 January 2023 : Clinical Research
Determining the Impact of the COVID-19 Pandemic on Dental Care in the Serbian Adult Population: An Online Q...Med Sci Monit 2023; 29:e939238
In Press
30 Mar 2023 : Clinical Research
An Online Survey on the Relationship Between Positive Coping and Post-Traumatic Stress Symptoms (PTSS) of M...Med Sci Monit In Press; DOI: 10.12659/MSM.939485
30 Mar 2023 : Database Analysis
Global Research Trends and Hotspots in Lateral Epicondylitis During the Past 30 Years: A Bibliometric and V...Med Sci Monit In Press; DOI: 10.12659/MSM.939309
29 Mar 2023 : Editorial
Editorial: Effective Direct-Acting Antiviral Treatments Support Global and National Programs to Eliminate H...Med Sci Monit In Press; DOI: 10.12659/MSM.940519
29 Mar 2023 : Laboratory Research
Preparation, Physicochemical Properties, and Structural Characterization of Resistant Starch-Aspirin-Loaded...Med Sci Monit In Press; DOI: 10.12659/MSM.939711
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952